Ebola Hemorrhagic Fever (Ebola HF) (cont.)
Charles Patrick Davis, MD, PhD
Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.
Jerry R. Balentine, DO, FACEP
Dr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident.
In this Article
- Ebola hemorrhagic fever (Ebola virus disease) facts
- What is Ebola hemorrhagic fever?
- What is the history of Ebola hemorrhagic fever?
- What causes Ebola hemorrhagic fever?
- What are risk factors for Ebola hemorrhagic fever?
- What are Ebola virus disease symptoms and signs?
- How do physicians diagnose Ebola hemorrhagic fever?
- What is the treatment for Ebola hemorrhagic fever?
- What are complications of Ebola hemorrhagic fever?
- What is the prognosis of Ebola hemorrhagic fever?
- Is it possible to prevent Ebola hemorrhagic fever? Is there a vaccine for Ebola hemorrhagic fever?
- What is the latest research on Ebola hemorrhagic fever?
- What is the latest news about the Ebola outbreak?
- Ebola Virus Slideshow Pictures
- Take the MRSA Quiz!
- Bacterial Infections 101 Slideshow Pictures
- Find a local Doctor in your town
What is the treatment for Ebola hemorrhagic fever?
According to the CDC and others, standard treatment for Ebola hemorrhagic fever is still limited to supportive therapy. Supportive therapy is balancing the patient's fluid and electrolytes, maintaining their oxygen status and blood pressure, and treating such patients for any complicating infections. Any patients suspected of having Ebola hemorrhagic fever should be isolated, and caregivers should wear protective garments. Currently, there is no vaccine or specific treatment for Ebola hemorrhagic fever.
What are complications of Ebola hemorrhagic fever?
Ebola hemorrhagic fever often has many complications; organ failures, severe bleeding, jaundice, delirium, shock, seizures, coma, and death (about 50% to 100% of infected patients). Those patients fortunate enough to survive Ebola hemorrhagic fever still may have complications that may take many months to resolve. Survivors may experience weakness, fatigue, headaches, hair loss, hepatitis, sensory changes, and inflammation of organs (for example, the testicles and the eyes).
What is the prognosis of Ebola hemorrhagic fever?
The prognosis of Ebola hemorrhagic fever is often poor; the death rate of this disease ranges from about 50% to 100%, and those who survive may experience the complications listed above.
Viewers share their comments
Find out what women really need.